(NYSE: CHE) Chemed's forecast annual revenue growth rate of 6.62% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.43%.
Chemed's revenue in 2024 is $2,264,417,000.On average, 1 Wall Street analysts forecast CHE's revenue for 2024 to be $36,628,413,997, with the lowest CHE revenue forecast at $36,628,413,997, and the highest CHE revenue forecast at $36,628,413,997. On average, 1 Wall Street analysts forecast CHE's revenue for 2025 to be $38,960,830,276, with the lowest CHE revenue forecast at $38,960,830,276, and the highest CHE revenue forecast at $38,960,830,276.
In 2026, CHE is forecast to generate $41,148,727,146 in revenue, with the lowest revenue forecast at $41,148,727,146 and the highest revenue forecast at $41,148,727,146.